Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes
- PMID: 2108023
- DOI: 10.1111/j.1432-1033.1990.tb15404.x
Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes
Abstract
A series of possible transition state analogues of the glucuronidation reaction catalyzed by UDP-glucuronosyltransferase were tested for their inhibitory effect on glucuronidation of various substrates in a rat liver microsomal fraction. In general 4-nitrophenol glucuronidation was more effectively inhibited than that of 1-naphthol, bilirubin or testosterone. 2-(1-Naphthyl)ethyl-UDP and 2,2,2-(triphenyl)ethyl-UDP were the most effective inhibitors. Their inhibitory effect was competitive towards both UDP-glucuronic acid and 4-nitrophenol. These compounds were much more effective inhibitors than UDP; therefore addition of a lipophilic group enhances the inhibitory potency of UDP. The various UDP derivatives showed differences in their abilities to inhibit the glucuronidation of the four acceptor substrates, supporting the concept that the different forms of UDP-glucuronosyl transferase have different active sites.
Similar articles
-
Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives.Biochem Biophys Res Commun. 1992 Aug 31;187(1):140-5. doi: 10.1016/s0006-291x(05)81470-6. Biochem Biophys Res Commun. 1992. PMID: 1520294
-
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12. Drug Metab Dispos. 2008. PMID: 17998297
-
Novel inhibitors and substrates of bilirubin: UDP-glucuronosyltransferase. Arylalkylcarboxylic acids.Eur J Biochem. 1989 Aug 15;183(3):653-9. doi: 10.1111/j.1432-1033.1989.tb21095.x. Eur J Biochem. 1989. PMID: 2776759
-
The bilirubin diglucuronide controversy.J Hepatol. 1985;1(4):437-42. doi: 10.1016/s0168-8278(85)80781-9. J Hepatol. 1985. PMID: 3932512 Review. No abstract available.
-
Glucuronidation: a dual control.Gen Pharmacol. 1998 Nov;31(5):683-8. doi: 10.1016/s0306-3623(98)00114-1. Gen Pharmacol. 1998. PMID: 9809463 Review.
Cited by
-
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.Agents Actions. 1993 Mar;38(3-4):178-87. doi: 10.1007/BF01976209. Agents Actions. 1993. PMID: 8213344
-
UDP-glucuronosyltransferase inhibitors.Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):453-6. doi: 10.1007/BF03189994. Eur J Drug Metab Pharmacokinet. 1998. PMID: 10323326 Review. No abstract available.
-
Cytosylglucuronic acid synthase (cytosine: UDP-glucuronosyltransferase) from Streptomyces griseochromogenes, the first prokaryotic UDP-glucuronosyltransferase.J Bacteriol. 1994 Mar;176(5):1282-6. doi: 10.1128/jb.176.5.1282-1286.1994. J Bacteriol. 1994. PMID: 8113166 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources